glp-1 and stroke Receptor Agonists Show Preclinical Neuroprotection - European Medical Journal GLP-1 Receptor Agonists Show Preclinical Stroke Neuroprotection 🧬 GLP-1s are not just

Those taking 3 mg of liraglutide lost 6% of their body weight, those taking 1.8 mg lost 4.7%, and those on the placebo lost 2%

For a deeper look at the science behind these medications, see our complete GLP-1 medications guide

Schwarz J, Trenkwalder C, Gasser T, Arnold G, Oertel WH

For male mice, there were significant increases in alternation percentages in transgenic male mice treated with intranasal GHK-Cu compared to transgenic male mice treated with intranasal saline starting the first month and continuing for the next 2 months of the study (Figure 1B)

Nutrition plays a foundational role in regenerative and peptide-based therapies

TLR-4 is a key mediator of innate immune activation, activated by gut-derived LPS, leading to an exaggerated inflammatory response